Yegodayev KM - Search Results

1

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.

Prasad M, Zorea J, Jagadeeshan S, Shnerb AB, Mathukkada S, Bouaoud J, Michon L, Novoplansky O, Badarni M, Cohen L, Yegodayev KM, Tzadok S, Rotblat B, Brezina L, Mock A, Karabajakian A, Fayette J, Cohen I, Cooks T, Allon I, Dimitstein O, Joshua B, Kong D, Voronov E, Scaltriti M, Carmi Y, Conde-Lopez C, Hess J, Kurth I, Morris LGT, Saintigny P, Elkabets M. Prasad M, et al. Among authors: yegodayev km. J Immunother Cancer. 2022 Mar;10(3):e003917. doi: 10.1136/jitc-2021-003917. J Immunother Cancer. 2022. PMID: 35292516 Free PMC article.

2

MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.

Novoplansky O, Fury M, Prasad M, Yegodayev K, Zorea J, Cohen L, Pelossof R, Cohen L, Katabi N, Cecchi F, Joshua BZ, Popovtzer A, Baselga J, Scaltriti M, Elkabets M. Novoplansky O, et al. Int J Cancer. 2019 Aug 1;145(3):748-762. doi: 10.1002/ijc.32170. Epub 2019 Feb 11. Int J Cancer. 2019. PMID: 30694565 Free PMC article.

3

Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy.

Ghosh S, Prasad M, Kundu K, Cohen L, Yegodayev KM, Zorea J, Joshua BZ, Lasry B, Dimitstein O, Bahat-Dinur A, Mizrachi A, Lazar V, Elkabets M, Porgador A. Ghosh S, et al. Among authors: yegodayev km. Front Oncol. 2019 Jan 22;9:17. doi: 10.3389/fonc.2019.00017. eCollection 2019. Front Oncol. 2019. PMID: 30723707 Free PMC article.

4

Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.

Badarni M, Prasad M, Balaban N, Zorea J, Yegodayev KM, Joshua BZ, Dinur AB, Grénman R, Rotblat B, Cohen L, Elkabets M. Badarni M, et al. Among authors: yegodayev km. JCI Insight. 2019 Mar 12;5(8):e125341. doi: 10.1172/jci.insight.125341. JCI Insight. 2019. PMID: 30860495 Free PMC article.

5

TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer.

Yegodayev KM, Novoplansky O, Golden A, Prasad M, Levin L, Jagadeeshan S, Zorea J, Dimitstein O, Joshua BZ, Cohen L, Khrameeva E, Elkabets M. Yegodayev KM, et al. Cancers (Basel). 2020 Feb 3;12(2):339. doi: 10.3390/cancers12020339. Cancers (Basel). 2020. PMID: 32028632 Free PMC article.

6

IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer.

Badarni M, Prasad M, Golden A, Bhattacharya B, Levin L, Yegodayev KM, Dimitstein O, Joshua BZ, Cohen L, Khrameeva E, Kong D, Porgador A, Braiman A, Grandis JR, Rotblat B, Elkabets M. Badarni M, et al. Among authors: yegodayev km. Cancers (Basel). 2021 May 7;13(9):2250. doi: 10.3390/cancers13092250. Cancers (Basel). 2021. PMID: 34067117 Free PMC article.

7

The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment.

Greenshpan Y, Sharabi O, Yegodayev KM, Novoplansky O, Elkabets M, Gazit R, Porgador A. Greenshpan Y, et al. Among authors: yegodayev km. Int J Mol Sci. 2022 Jul 4;23(13):7431. doi: 10.3390/ijms23137431. Int J Mol Sci. 2022. PMID: 35806439 Free PMC article.

8

Assessment of parathyroid gland cellularity by digital slide analysis.

Sagiv R, Delgado B, Lavon O, Osipov V, Sade R, Shashar S, Yegodayev KM, Elkabets M, Joshua BZ. Sagiv R, et al. Among authors: yegodayev km. Ann Diagn Pathol. 2022 Jun;58:151907. doi: 10.1016/j.anndiagpath.2022.151907. Epub 2022 Jan 31. Ann Diagn Pathol. 2022. PMID: 35299079

9

Cell stiffness predicts cancer cell sensitivity to ultrasound as a selective superficial cancer therapy.

Bergman E, Goldbart R, Traitel T, Amar-Lewis E, Zorea J, Yegodayev K, Alon I, Rankovic S, Krieger Y, Rousso I, Elkabets M, Kost J. Bergman E, et al. Bioeng Transl Med. 2021 May 27;6(3):e10226. doi: 10.1002/btm2.10226. eCollection 2021 Sep. Bioeng Transl Med. 2021. PMID: 34589601 Free PMC article.

10

High parathyroid hormone levels after parathyroidectomy for parathyroid adenoma are not related to the cellularity of the remaining glands.

Sagiv R, Delgado B, Sadeh R, Shashar S, Fraenkel M, Yegodayev KM, Elkabets M, Joshua BZ. Sagiv R, et al. Among authors: yegodayev km. Laryngoscope Investig Otolaryngol. 2021 Sep 8;6(5):1220-1227. doi: 10.1002/lio2.644. eCollection 2021 Oct. Laryngoscope Investig Otolaryngol. 2021. PMID: 34667868 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page